BROADFOOT JILL MARIE (Chief Financial Officer) sold 3.8% of their position (1.25K shares) of ATYR PHARMA INC on the open market
Open‑market sale worth $4.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2025ACC: 0000950170-25-013884
Officer· Chief Financial Officer
Since Jul 2018
-1.25K
Net shares
Net seller
$4.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.75K acquired · 5K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
12.8%
2/3/2025
29.27K→33.02K
Common Stock
Direct
Shares
−1.25K
Price / share
$3.78
Trade value
$4.74K
% of position
3.8%
2/4/2025
33.02K→31.76K
Total
Net shares
+2.50K
Net value
-$4.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | M · Option Exercise | +3.75K | — | — | 12.8% | 29.27K | 33.02K |
| Common Stock Direct | 2/4/2025 | S · Sale | −1.25K | $3.78 | $4.74K | 3.8% | 33.02K | 31.76K |
| Total | +2.50K | -$4.74K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
3.75K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.75K shares | 2/3/2025 | M · Option Exercise | −3.75K | — | 3.75K |